← Eichor
Condition: Asthma Eosinophilic Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Asthma Eosinophilic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Phase 3 · 50 location(s) · GlaxoSmithKline · NCT06979323A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eos
Phase 3 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT06653322Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Phase N/A · 3 location(s) · Matthias Griese · NCT02852928Real Life Study of Biologicals in Patients With Severe CRSwNP
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05938972Allergy and Immunology Natural History Study
Phase N/A · 1 location(s) · Columbia University · NCT05584488Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Phase 2 · 1 location(s) · National Jewish Health · NCT02947945Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · 160 location(s) · AstraZeneca · NCT06750289A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Phase 2 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT06441812Therapeutic Relevance of Abnormal Airway Morphology in Asthma
Phase 4 · 2 location(s) · McMaster University · NCT06970080A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Phase N/A · 28 location(s) · AstraZeneca · NCT07214753SIM0718 Treatment of Asthma Clinical Study
Phase 3 · 1 location(s) · Simcere Pharmaceutical Co., Ltd · NCT06488755This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patient
Phase N/A · 36 location(s) · AstraZeneca · NCT06862206Efficacy and Safety Study of 610 in Patients With Severe Asthma
Phase 3 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT06323213
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.